Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRQoL assessment and communication during etanercept treatment for psoriasis
NL-OMON24504Phase 4Recruiting
- Sponsor
- Stichting Aquamarijn
- Start
- Oct 2008
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of etanercept in plaque psoriasis (2 arms), sponsored by Stichting Aquamarijn. Primary endpoints: Communication Questionnaire and Dermatology Life Quality Index. Started Oct 2008; status: recruiting.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NL-OMON24504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24504.